Evidence of unexpected rapid progression of lymphomatous lesions was
detected in a man recently diagnosed with angioimmunoblastic T-cell
lymphoma (AITL) a rare, often but not always, aggressive (fast-growing)
form of peripheral T-cell lymphoma, according to a case report analyzed by six health experts.
Angioimmunoblastic T-cell lymphoma (AITL) is a type of T-cell lymphoma – non-Hodgkin lymphoma that develops from white blood cells called T cells.
ichael Goldman,
a Belgian pro-vaccine doctor and a professor at the Free University of
Brussels, Belgium specializing in internal medicine and immunology, was
diagnosed with lymphoma, a general term for cancers that start in the
lymph system.
** The Gateway Pundit wrote about Goldman’s case previously.
Goldman and his colleagues published his case report in Frontiers of Medicine last year, titled “Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report.”
From the case report:
“A 66-year-old man with no significant medical history except for
hypertension, hypercholesterolemia and type 2 diabetes presented on
September 1, 2021 with cervical lymphadenopathies that became recently
apparent during a flu-like syndrome. The two doses of BNT162b2 mRNA
vaccine had been administered, respectively, 5 and 6 months earlier in
the left deltoid. Besides moderate asthenia, he did not report any
constitutional symptom. Blood examination indicated a mild inflammatory
syndrome, without anemia or white blood cell changes; Lymphocytes
immunophenotyping was unremarkable. Protein electrophoresis and
immunoglobulin levels were normal and Coombs test was negative.”
On September 22, 2021, Goldman was eager to receive the mRNA vaccine
booster dose. As he was about to undergo chemotherapy that would leave
him immunocompromised, he was concerned about not being protected enough
from Covid-19.
Within a few days of being boosted, Goldman’s cancer symptoms —
including night sweats, tiredness, and enlarged lymph nodes — worsened.
More from Newsbreak:
He then took another computed tomography (CT) scan. And the results were horrific.
“The pictures showed a brand-new barrage of cancer
lesions — so many spots that it looked like someone had set off
fireworks inside [Goldman’s] body,” Khamsi described. “More than that,
the lesions were now prominent on both sides of the body, with new
clusters blooming in [Goldman’s] right armpit in particular, and along
the right side of his neck.”
Such cancer progression within three weeks is uncanny given what we
know about the natural course of lymphoma, and Goldman needed steroids
as soon as possible. Goldman began to suspect that the booster shot had
somehow worsened his lymphoma, making his chance of survival for more
than five years at only 30%.
Before getting boosted, the lymphoma was only limited to Goldman’s
left armpit and neck. Coincidentally, Goldman received his first and
second mRNA vaccine dose on the left arm. But Goldman received the
booster on the right arm, and the lymphoma began appearing therein.
Newsbreak author Shin Jie Yong,
an MSC Biology student reported what he learned from a professor who
told him about seven patients with stage IV tumors that were
well-controlled for almost five years but suddenly progressed after
receiving the Covid-19 vaccination.
He [professor] theorized that vaccination, or any other immune
stimulant for that matter, disturbed the delicate balance in the immune
surveillance of cancer cells.
Second, lymphadenopathy (swollen lymph nodes) is a common adverse event associated with mRNA vaccines. A nationwide surveillance study from
Israel found that the mRNA vaccine (Pfizer-BioNTech) is associated with
a 2.4-times increased risk of lymphadenopathy compared to no vaccine,
with an excess of 78 cases per 100,000 vaccines.
A meta-analysis of
nine studies examining changes in 18F-FDG PET/CT scans after Covid-19
(mainly mRNA) vaccination revealed that 37% of vaccinees developed
axillary lymphadenopathy on the same side as the shot due to
vaccine-related immune responses. Since such vaccine-related axillary
lymphadenopathy is similar to certain cancers, so they may get
misdiagnosed as cancer. Patients at risk of cancer spread to axillary
lymph nodes — e.g., breast cancer, melanoma, and lymphomas —are thus advised to get vaccinated in the arm opposite to the cancer side.
Third, certain mutations within the lymphomas might make them more sensitive to mRNA vaccines. A 2018 study showed
that mice with RHOA G17V and TET2 mutations — which were also present
in Goldman’s lymphoma — developed lymphoma upon immunization with sheep
red blood cells. And it was the RNA present in the sheep’s red blood
cells that was responsible for the immunization. And mRNA is a type of
RNA.
Pro-vaccine advocate Michael Goldman, then 66 years old, was
challenged whether or not to report the life-threatening adverse event
he had after receiving a vaccine, per Shin. In the end, Goldman and his
colleagues decided to publish their findings.
A comparison of Goldman’s 18F-FDG PET/CT scans taken before and after
he had the mRNA vaccination booster shot is shown below. the black
spots, with the exception of the brain, show lymphadenopathies, which
are signs of cancer spreading.
The case report suggested that vaccination with the Pfizer mRNA vaccine might induce rapid progression of AITL.
“To the best of our knowledge, this is the first observation
suggesting that administration of a SARS-CoV-2 vaccine might induce AITL
progression. Several arguments support this possibility. First, the
dramatic speed and magnitude of the progression manifested on two
18F-FDG PET-CT performed 22 days apart. Such a rapid evolution would be
highly unexpected in the natural course in the disease. Since mRNA
vaccination is known to induce enlargement and hypermetabolic activity
of draining lymph nodes, it is reasonable to postulate that it was the
trigger of the changes observed,” said the experts.
According to a recent study published on the Harvard website, there is a dramatic rise in cancer in people under 50.
“A study
by researchers from Brigham and Women’s Hospital reveals that the
incidence of early onset cancers — including breast, colon, esophagus,
kidney, liver, and pancreas — has dramatically increased around the
world.”
CNN reported:
A new review of
cancer registry records from 44 countries found that the incidence of
early-onset cancers is rising rapidly for colorectal and 13 other types
of cancers, many of which affect the digestive system, and this increase
is happening across many middle- and high-income nations.
The review’s authors say the upswing in younger adults in happening
in part because of more sensitive testing for some cancer types, such as
thyroid cancer. But testing doesn’t completely account for the trend,
says co-authorShuji Ogino, a professor of pathology at the Harvard T.H.
Chan School of Public Health.
Ogino says the spike is due to an unhealthy stew of risk factors that
are probably working together, some which are known and others that
need to be investigated.
Dr. James Olsson noticed that there seems to be a greater than usual number of reports of cancers.
Below is a screenshot of his tweet regarding cancer cases.
Read the rest of the article by clicking on the link at top
